BALAXI PHARMACEUTICALS LIMITED — Others, 25-02-2025: Shareholders meeting

Balaxi Pharmaceuticals has announced a board meeting to seek shareholder approval via postal ballot for the remuneration of Mr. Ashish Maheshwari, Managing Director. The proposed remuneration is Rs. 80,00,000 per annum, remaining unchanged for the period from April 2025 to May 2027. The company emphasizes that in case of inadequate profits, this amount can still be paid as a minimum. The e-voting will take place from February 26 to March 27, 2025. This continuity in leadership and consistent remuneration reflects a strategic commitment to maintaining stability, which could foster a positive outlook among investors amidst recent operational challenges.